Efficacy & Safety of SCH 900435 in Schizophrenia (Study P06079)(WITHDRAWN)

Summary

The purpose of this study is to assess whether SCH 900435 (Org 25935) 16 mg twice daily is more effective than placebo in the treatment of patients with schizophrenia, using olanzapine 15 mg once daily as active control.

Timeline

Start

2011-02

Primary completion

2012-07

Completion

2012-07

Drugs

Indications